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ABSTRACT: A decrease in the tubular expression of albumin endocytic transporters megalin and cubilin has been 
associated with diabetic nephropathy, but there are no comprehensive studies to date relating early tubulointerstitial 
injury and the effect of the disease on both transporters in type 1 diabetes mellitus (T1DM). We used eight-week-
old male C57BL/6 mice divided into two groups; one of them received the vehicle (control group), while the other 
received the vehicle + 200 mg/kg streptozotocin (T1DM). Ten weeks after the injection, we evaluated plasma insulin, 
enzymuria, urinary vitamin D-binding protein (VDBP), tubulointerstitial fibrosis and proximal tubule histology, 
markers of autophagy, and megalin and cubilin levels. We found a reduction in tubular protein reabsorption 
(albumin and VDBP as specific substances carried by both transporters) with increased tubulointerstitial injury, 
development of fibrosis, thickening of tubular basement membrane, and an increase in tubular cell metalloproteases. 
This was associated with a decrease in the renal expression of megalin and cubilin. We also observed an increase 
in the amount of cellular vesicles of the phagocytic system in the tubules, which could be linked to an alteration of 
normal intracellular trafficking of both receptors, thus affecting the normal function of transporters in early stages of 
diabetic nephropathy. In diabetic animals, the added effects of tubulointerstitial injury, the decreases in megalin and 
cubilin expression, and an altered intracellular trafficking of these receptors, seriously affect protein reabsorption.
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Introduction
Diabetic nephropathy is one of the major causes of chronic 
kidney disease worldwide and is defined as a rise in the urinary 
albumin excretion rate with abnormal renal function (Gross, 
JL et al., 2005). Early proteinuria in diabetic nephropathy 
involves glomerular and tubular alterations (Gibb, D et al., 
1989), with albuminuria (micro- to macroalbuminuria) being 
one of the central markers of disease progression (Moresco, 
RN et al., 2013). Diabetes mellitus encompasses structural 
changes in all compartments of the kidney. An increase in 
the amount of renal interstitium correlates with an alteration 
of the glomerular filtration rate and is indicative of disease 
progression in type 1 diabetes mellitus (T1DM) (Lane, PH et 
al., 1993; White, KE & Bilous, RW, 2000).
Until now, much has been learned about the role of the 
glomerulus and vasculature in the pathogenesis of diabetic 
nephropathy, and the role of tubulointerstitial changes in 
early diabetic nephropathy have recently received growing 
attention (Kanwar, YS et al., 2008; Loefﬂer, I, 2012; Vallon, 
V & Thomson, SC, 2012; Vallon, V, 2014).
The initial phase of diabetic nephropathy is character-
ized by kidney hyperplasia followed by hypertrophy with ele-
vated glomerular filtration rate (Blantz, RC & Singh, P, 2014). 
Likewise, tubular growth explains the hyper-reabsorption 
observed at early stages of diabetic nephropathy and contrib-
utes to glomerular hyper-filtration and the progression of 
renal disease to tubulointerstitial inflammation and fibrosis 
(Vallon, V, 2011; Vallon, V & Thomson, SC, 2012). Disease 
progression also correlates with tubular hypertrophy (Huang, 
H-C & Preisig, PA, 2000; Amiri, F et al., 2002; Efendiev, R et 
al., 2003) and differentiation of tubulointerstitial cells into 
extracellular matrix-producing myofibroblasts (Kanasaki, K 
et al., 2013), with the formation of atubular glomeruli and 
interstitial fibrosis (Meyer, TW, 2003). 
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2FIGURE 1. Experimental design. During the evo-
lution of the disease, all animals were weighed 
and blood glucose was controlled every two 
weeks. After the development of diabetic ne-
phropathy (10 weeks after STZ administration), 
renal function and structure were evaluated. 
T1DM, type 1 diabetes mellitus; STZ, streptozo-
tocin; VDBP, vitamin D-binding protein; α-SMA, 
alpha-smooth muscle actin LBPA: lysobisphos-
phatidic acid, TEM: transmission electron mi-
croscopy. 
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Normally, around 95% of filtered albumin is reabsorbed 
in the proximal tubule (Bourdeau, J & Carone, F, 1974). The 
most important endocytic retrieval pathway is mediated by 
the action of two protein binding receptors: megalin and 
cubilin (Christensen, EI & Birn, H, 2001; Christensen, EI 
et al., 2012). 
Megalin (≈600 KDa) is a transmembrane glycoprotein 
expressed in the brush border membrane and endocytic 
apparatus of the proximal tubule. This protein is the main 
transporter for endocytosis of albumin and other low 
molecular weight proteins, such as vitamin D-binding 
protein (VDBP) (Christensen, EI et al., 2012). Cubilin (≈460 
KDa) is a cooperating extracellular glycoprotein anchored to 
the tubular cell surface. This transporter is the main receptor 
for large molecular weight proteins and interacts with 
megalin, regulating its endocytic function (Christensen, 
EI et al., 2012). The interaction between both receptors is 
important because megalin mediates the internalization of 
cubilin and its ligands (Hammad, SM et al., 2000). However, 
cubilin can form a functional complex with amnionless called 
CUBAM, which is translocated to the plasma membrane 
and displays megalin-independent activity (Coudroy, G et 
al., 2005; Christensen, EI et al., 2012; Christensen, EI et al., 
2013). At the cellular level, megalin and cubilin are present 
in microvilli, coated pits, and subsequent compartments of 
the endocytic route. However, before entering lysosomes, the 
majority is recycled to the apical membrane (Christensen, EI 
et al., 2012). Both albumin transporters have been postulated 
as mediators that participate in renal disease (Christensen, 
EI et al., 2012), but the underlying pathogenic mechanisms 
remain unclear (Nielsen, R et al., 2016). The overload of 
tubular proteins and the alteration of tubular albumin 
receptors have a deleterious effect in the cells and have 
been associated with the presence of proinflammatory and 
profibrotic mediators that lead cells to apoptosis and tissue 
damage (Abbate, M et al., 2006; Caruso-Neves, C et al., 
2006). Likewise, changes in the expression of these receptors 
have been reported in chronic diseases such as hypertension 
and diabetes (Tojo, A et al., 2003; Thrailkill, KM et al., 2009; 
Whaley-Connell, A et al., 2011; Ogasawara, S et al., 2012). 
Increased urinary excretion of megalin and cubilin has 
been found in human diabetic patients (Thrailkill, KM et 
al., 2009; Ogasawara, S et al., 2012), which could be related 
to a process called “regulated intramembrane proteolysis”, 
where metalloproteases (MMP) cause shedding of the 
receptor’s ectodomain (Biemesderfer, D, 2006; Christensen, 
EI et al., 2012).
As far as we know, there are no comprehensive studies 
regarding the effect of tubulointerstitial injury induced by 
T1DM on the expression and function of the albumin en-
docytic transporters megalin and cubilin. Therefore, con-
sidering that diabetes is a multifactorial disease and that 
glomerular alterations are well characterized and play an 
important role in the development of albuminuria, we focus 
our study on the role of the tubule in a murine model of 
early diabetic nephropathy induced by T1DM. The specific 
aims of our study were (1) to evaluate the expression and 
function of megalin and cubilin during tubulointerstitial 
injury, and (2) to explore the possible pathogenic factors 
related to the alteration of these transporters, with special 
focus on autophagy.
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Materials and Methods
Animals
Male C57BL/6 mice (Jackson Laboratory) were housed at 
constant temperature (22 ± 2 °C) and 60% relative humid-
ity, with a 12:12 h light-dark cycle and unrestricted access 
to a standard rodent diet and autoclaved water. When re-
quired, animals were slightly anaesthetized with sevoflu-
rane (Abbott, Japan) or ketamine (Drag Pharma) plus xyla-
zine (Centrovet). All procedures were in accordance with 
the Ethics Committee of Facultad de Medicina, Clínica 
Alemana-Universidad del Desarrollo and Animal Welfare 
Assurance Publications A54427-01, Office for Protection 
from Research Risks, Division of Animal Welfare, NIH 
(National Institute of Health), Bethesda, MD, USA.
Induction of type 1 diabetes and sample collection
Eight-week-old male C57BL/6 mice were slightly anesthe-
tized and received, via intraperitoneal injection, 200 mg/
kg streptozotocin (STZ; Sigma-Aldrich) in 0.1M at pH 4.5 
(T1DM mice) or citrate buffer only (control mice) (Fig. 1). 
This protocol of STZ administration causes massive cy-
totoxic destruction of insulin producing cells, generating 
severe hypoinsulinemic/hyperglycemic conditions and the 
development of diabetic nephropathy (Breyer, MD et al., 
2005; Ezquer, F et al., 2009). This experimental model of 
diabetic nephropathy has been characterized in our labo-
ratory and a discrete acute nephrotoxic effect has been ob-
served after STZ administration, with no evidence of glo-
merular or tubular histopathological alterations (Katoh, 
M et al., 2000; Tay, YC et al., 2005; Ezquer, F et al., 2015). 
Therefore, this animal model of diabetes mellitus has been 
previously recommended as an experimental model of early 
diabetic nephropathy (Breyer, MD et al., 2005; Tesch, GH 
& Nikolic-Paterson, DJ, 2006; Alpers, CE & Hudkins, KL, 
2011). After 10 weeks of disease evolution, diabetic animals 
were sacrificed along with their corresponding controls.
Urine collection and physical and biochemical deter-
minations were made every two weeks up to the end of the 
study, when the animals were euthanized and plasma and 
kidney samples were obtained. For urine collection, mice 
were kept in metabolic cages for morning spot urine collec-
tion after they spontaneously urinated (Ezquer, F et al., 2009). 
Samples were centrifuged to remove any suspended particles 
and the supernatants were used for the determination of al-
bumin, VDBP, and the enzymes alkaline phosphatase (ALP) 
and gamma-glutamyl transferase (GGT). After sacrifice, one 
kidney was fixed in 4% paraformaldehyde solution for im-
munohistochemical assessment, while the other was divided 
into two cortex sections and flash-frozen for gene expression 
analysis, Western blot, and ELISA detections.
Physical and biochemical determinations
Body weight, kidney weight, renal mass index (deter-
mined by the ratio of kidney weight to body weight), and 
biochemical parameters were measured during the ex-
periments. Blood glucose levels were measured with a 
glucometer (ACCU-CHEK II; Roche Diagnostics, USA). 
Insulin plasma levels were measured using a mouse-specif-
ic insulin ELISA kit (Ultrasensitive Mouse Insulin ELISA, 
Mercodia, Sweden). Albuminuria was determined using a 
mouse-specific albumin ELISA kit (Albuwell, Exocell, USA) 
FIGURE 2. Physical and biochemical param-
eters of control and T1DM animals after 10 
weeks of diabetes. (A) Body weight. (B) Blood 
glucose determinations of venous blood sam-
ples obtained from alert nonfasted animals. 
(C) Plasma insulin levels determined in venous 
blood samples obtained from the same animals 
at the end of the experiment. (C and E) Animal 
kidney weight and renal mass index (ratio of 
kidney weight to body weight) for experimental 
groups. Values are mean ± SEM, N = 6. Signif-
icant differences between diabetic and control 
animals are indicated with asterisks or horizon-
tal brackets (Student’s t-test, P<0.05). 
4as a specific marker of diabetic nephropathy development. 
Urine creatinine concentration was determined using the 
Creatinine Companion kit (Exocell, USA). The presence of 
VDBP in the urine was measured using a mouse-specific 
VDBP ELISA kit (BIOMATIK, USA) as a specific marker 
of megalin and cubilin function. Urinary alkaline phos-
phatase (ALP) was measured according to the International 
Federation of Clinical Chemistry and Laboratory Medicine 
(IFCC) kinetic method (Tietz, N et al., 1983) and urinary 
gamma-glutamyl transferase (GGT) was measured accord-
ing to the Deustche Gesellschaft für Klinische Chemie 
(DGKC) kinetic method (Szasz, G, 1969). Both enzymes 
were used as markers of proximal tubule cell damage be-
cause damaged cells release ALP and GGT into urine (Raab, 
WP, 1972; Hong, CY & Chia, KS, 1998). Protein concen-
trations were determined according to Bradford (1976). 
Urinary ALP, GGT, albumin, and VDBP were normalized 
to urine creatinine concentration.
Histochemical analysis
For the evaluation of tubulointerstitial fibrosis, we analyzed 
interstitial collagen deposition by a modified point-counting 
technique (Møller, JC & Skriver, E, 1985) on tissue sections 
stained following the Masson Trichrome method. The 
relative volume (Vv) of collagen deposition was expressed 
as the mean percentage of grid points lying within the 
interstitial area in up to ten fields in the renal cortex. All 
consecutive fields of renal cortex were randomly selected 
and photographed at 400X. A 10x10 grid was superimposed 
on each photograph (Photoshop® software) and 1000 points 
were evaluated in each case. The number of points overlaying 
tubular basement membranes and collagen interstitial 
deposits were counted, while points falling on glomerular 
structures or peritubular capillaries were excluded from the 
total count. 
Transmission electron microscopy (TEM)
One- or two-millimeter-thick slices of kidney cortex were 
obtained and fixed for 5 h in a 4% paraformaldehyde-2.5% 
glutaraldehyde mixture in 0.1 M sodium phosphate buffer 
at pH 7.4 and washed three times (10 minutes each) with 
the same buffer. The samples were post-fixed overnight with 
1% osmium tetroxide and 2% uranyl acetate for 45 minutes 
and subsequently dehydrated via graded ethanol and acetone 
before being embedded in Spurr’s resin. Ultrathin sections 
were obtained, the contrasted sections (uranyl acetate and 
lead citrate) were examined with a Zeiss 902 microscope, and 
digital micrographs were taken.
Immunofluorescence (IFI) analysis
Tissue sections 4-μm-thick were deparaffinized in Neo-
Clear (Merck), rehydrated and incubated in 10 mM citrate 
buffer at pH 6, in a boiling water bath for 40 minutes, for 
antigen retrieval. The sections were then washed three times 
in tris-buffered saline and Tween 20 (0.1%) (TBS-T) for 10 
minutes each, pre-incubated in blocking solution (5% goat 
or fetal bovine serum in PBS) for 60 minutes, washed three 
times in TBS-T and then incubated with primary antibody in 
TBS-T overnight at 4°C. The primary antibodies used were: 
alpha-smooth muscle actin (α-SMA, ab5694, AbCAM), 
megalin (sc-16478, Santa Cruz), cubilin (sc-20609, Santa 
Cruz), lysobisphosphatidic acid (LBPA, Molecular Probes), 
albumin (NB110-16329, Novus Biologicals), and matrix 
metalloproteinase 2 (MMP-2, sc-6838, Santa Cruz). Each 
section was then washed three times in TBS-T and incubated 
with a secondary antibody in TBS-T for 60 minutes at room 
temperature. Donkey anti-goat Alexa-Fluor 555 conjugated 
serum (Invitrogen) or Goat Anti-rabbit Alexa Fluor (R) 
555 (Molecular Probes) were used as secondary antibodies. 
After washing the sections three times with TBS-T, they 
were counterstained with 4’,6-diamidino-2-phenylindole 
FIGURE 3. Electron microscopy assessment of proximal tubules of control 
(A and C) and T1DM animals (B, D, E-J). (A and B) Surface of epithelial 
cells and their microvilli (Mv). (C and D) Tubular basement membranes 
(BM) of both experimental groups. (E-J) Double membrane structures 
containing undigested cytoplasmic material (arrowheads) and secondary 
lysosomes and late endosomes (arrows) that correspond to phagocytic 
structures from tubular cells of T1DM animals. Scale bars: A-G and I: 1 
μm; H and J: 0.5 μm.
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5(DAPI) (BioChemica A1001, AppliChem). The samples 
were examined with a Fluoview FV10i confocal microscope 
(Olympus). Negative controls without the corresponding 
primary antibody were used to observe tissue background. 
The scores of twenty randomly selected fields of renal cortex 
tubulointerstitium were averaged for each animal, and the 
scores of six separate animals were then averaged for each 
group. All the figures obtained were randomly chosen and 
blindly analyzed by the same nephrology specialist.
For the semiquantitative analysis of α-SMA and MMP-
2 in the kidney, we established a score, modified from the 
method described by Ishidoya et al. (1995). Briefly, twenty 
random, non-overlapping fields of immunohistochemically 
labeled sections were assigned a score of zero to three. The 
score was based on the relation of the tubulointerstitium 
with the specific antibody where 0 = changes affecting <25% 
of the sample, 1 = changes affecting 25% to 50% of the sam-
ple, 2 = changes affecting 50% to 75% of the sample, and 3 
= changes affecting >75% of the sample (Benigni, A et al., 
2004). 
The immunoreactivity of megalin and cubilin was quan-
tified using Image Pro-Plus 4.5® software (Media Cybernet-
ics, Silver Spring, MA, USA) and the results were expressed 
as the percentage of positive megalin/cubilin tubular area. 
For the analysis of the co-expression of LBPA and megalin 
or cubilin, we used a score analogous to the one previously 
described, but exploring the entire kidney cortex in each case 
(N = 4 for each experimental group) and assigning a score of 
0 = <25% of the proximal tubules show accumulation of LB-
PA-labeled vesicles, 1 = 25% to 50% of the tubules affected, 2 
= 50% to 75% of tubules affected, and 3 = >75% of alteration.
Western blot (WB) analysis
Immunoblot analysis was used to determine the total 
amount of megalin and cubilin receptors in the kidney 
and cubilin levels in urine. Tissue samples of kidney 
cortex were placed in ice-cold tissue protein extraction 
reagent (T-PER, Life Technologies) and homogenized. The 
homogenate was centrifuged at 10,500 rcf for 20 minutes 
at 4°C. The supernatants were aliquoted and kept at -80°C 
FIGURE 4. Evaluation of tubulointerstitial 
fibrosis in T1DM animals after 10 weeks of 
diabetes. (A-C) Relative volume (Vv) of collagen 
deposition in the renal cortical interstitium (point-
counting technique - Masson trichrome staining 
method). (D-F) Immunofluorescence analysis 
of matrix score for alpha-smooth muscle actin 
(α-SMA, arrowheads) expression in renal 
cortical interstitium. Values are mean ± SEM, 
N = 6. Horizontal brackets indicate significant 
differences between T1DM and control groups 
(Student’s t-test, P<0.05). Bars: A and B: 50 μm; 
D and E: 25 μm.
TABLE 1
RT-PCR specific primers and characteristics of amplicons






Megalin NM_001081088.1 AAAATGGAAACGGGGTGACTT GGCTGCATACATTGGGTTTTCA 170 85
Cubilin NM_001081084.2 CACTTTAGGTTGTGGTGGAACA TTGCTGTCAAAGCTAATCTCCC 147 83
GAPDH XM_001474390.1 ACTCCACTCACGGCAAATTC TCTCCATGGTGGTGAAGACA 171 88
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6until protein quantification. Loading buffer was mixed with 
the supernatant samples and boiled for 5 minutes before 
SDS-PAGE separation. Fifteen micrograms of protein from 
the kidney were loaded per lane. In all cases, the samples 
were separated by SDS-PAGE for 240 minutes at 40 mA 
and transferred onto a 0.2 μm nitrocellulose membrane for 
270 minutes at 90 V. Prestained molecular mass markers 
were used to determine the migration of proteins onto 
the membrane. The nitrocellulose filter was then blocked 
for 2 h in TBS-T blocking buffer, followed by overnight 
incubation at 4°C with each of the primary antibodies 
diluted 1:500 in TBS-T. The primary antibodies used were 
the same as described above for IFI analysis. The secondary 
peroxidase-conjugated donkey anti-goat IgG antibody 
(Jackson) was diluted 1:5000 in TBS-T. The bound antibody 
was detected by its chemiluminescence and revealed in an 
autoradiography film (Sigma-Aldrich). Expression of each 
protein (tissue megalin or cubilin) was normalized to actin 
expression. For the case of cubilin present in urine, the results 
of densitometric quantifications were normalized to the 
creatinine concentration in urine samples. Densitometric 
semiquantification of protein bands was performed using 
NIH image analysis software. Results were expressed as 
mean ± Standard Error of the Mean (SEM) for protein/actin 
or creatinine relative density units (RDU).
Renal gene expression analysis
Expression levels of megalin, cubilin, and GAPDH from 
kidney samples were assessed by quantitative RT-qPCR (de-
tails of specific primers were described in Table 1). Total 
RNA was purified using TRIzol (Invitrogen) and quantified 
spectrophotometrically at 260 nm. One μg of total RNA 
was used for reverse transcription. Real time PCR was per-
formed in a final volume of 10 μL containing 50 ng of cDNA, 
PCR LightCycler-DNA Master SYBRGreen reaction mix 
(Roche), 3 mM MgCl2, and 0.5 μM of each specific primer 
(Supplementary Table 1) using a Light-Cycler thermocycler 
(Roche). To ensure that amplicons were from mRNA and 
not from genomic DNA amplification, controls without re-
verse transcription were included. Amplicon validation was 
performed based on their size and melting point. Relative 
quantification was performed using the ΔΔCT method 
(Schmittgen, TD & Livak, KJ, 2008). The mRNA levels of 
each target gene were normalized against the mRNA level of 
GAPDH and expressed as fold change versus normal mice.
Statistical analysis
The distribution of variables was first evaluated using a 
Kolmogorov-Smirnov normality test, and Bartlett’s test for 
equal variances was used to evaluate homogeneity of vari-
ances for each set of experimental variables. The data were 
FIGURE 5. Evaluation of tubular function in 
T1DM animals after 10 weeks of diabetes. (A 
and B) Urinary excretion of tubular enzymes (ALP 
and GGT). (C) Albuminuria. (D) Urinary vitamin 
D-binding protein (VDBP) excretion. (E-J) Immu-
nolabeled intracellular albumin (arrowheads) in 
kidney cortical tubules from control and T1DM 
animals. Values are mean ± SEM, N = 6. Hor-
izontal brackets indicate significant differences 
between diabetic and control groups (Student’s 
t-test, P<0.05). Bars: E-J: 10 μm.
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7square-root transformed if variances differed significantly, 
and differences between groups of control and diabetic ani-
mals were evaluated by unpaired Student’s t-test. Significance 
level was set at P<0.05.
Results
Diabetic nephropathy model
After diabetes induction, hyperglycemia and body weight 
changes were observed in diabetic animals (Fig. 2 A and B).
Animals affected by diabetes showed a significant de-
crease in body weight compared with normal mice (Fig. 2 A). 
Also, blood glucose levels increased significantly after STZ 
administration in T1DM animals (Fig. 2 B). Ten weeks after 
diabetes induction, plasma insulin levels decreased by more 
than 95% in T1DM animals when compared with controls 
(Fig. 2 C). On the other hand, kidney size in T1DM animals 
was significantly greater than that observed in the control 
group, as quantified by the renal mass index and kidney 
weight (Fig. 2 D and E).
Tubulointerstitial injury induced in early diabetic nephropathy
One of the earliest morphological changes in diabetic ne-
phropathy is the tubular thickening of basement membrane 
(Brito, PL et al., 1998; Fioretto, P & Mauer, M, 2007; Singh, 
DK & Farrington, K, 2010). Under TEM, we observed a sig-
nificant increase in the thickness of the tubular basement 
membrane (control: 236.7 ± 19.0 μm vs. T1DM: 381.3 ± 36.8 
μm; mean ± SEM, Student t- test) (Fig. 3 C and D). We did 
not find significant microvilli alteration (Fig. 3 A and B) 
and peritubular capillary rarefaction, as has been described 
previously, probably because of the early stage of the disease 
(Harris, RD et al., 1991). However, we found signs of inter-
stitial fibrosis (analyzed below) and tubular atrophy with 
cellular alteration. Furthermore, we observed a marked in-
crease in the amount of vesicles that showed characteristics 
of autophagosomes (Mizushima, N, 2004; Eskelinen, E-L et 
al., 2011; Klionsky, DJ et al., 2012), with a double membrane 
structure containing undigested cytoplasmic material in-
cluding organelles such as mitochondria and lysosomes 
(Fig. 3 E-G and I). Also, a large amount of structures corre-
sponding to secondary lysosomes and late endosomes were 
found in many tubules of diabetic nephropathy mice (see 
below, Fig. 3 H and J). 
Tubulointerstitial injury in diabetic nephropathy 
animals was studied through structural parameters 
present during the progression of the disease. Initially, we 
explored the development of tubulointerstitial fibrosis via 
point counting. We observed a significant increase in the 
percentage of tubulointerstitial collagen deposits in T1DM 
FIGURE 6. Analysis of protein tubular transport-
ers megalin and cubilin in diabetic nephropathy 
induced after 10 weeks of T1DM. (A-C) Tubular 
megalin levels determined by immunofluores-
cence (arrowheads indicate megalin labeled 
brush border). (D-F) Tubular cubilin levels deter-
mined by immunofluorescence (arrowheads in-
dicate cubilin labeled brush border). (G and H) 
Quantitative megalin and cubilin RT-qPCR from 
the renal cortex (relative amount of megalin and 
cubilin mRNA was normalized to GAPDH mRNA 
expression). (I and J) Renal megalin and cubilin 
protein levels (measured by Western blot, RDU 
is relative density units of megalin or cubilin/
actin). Values are mean ± SEM, N = 6. Hor-
izontal brackets indicate significant differences 
between T1DM and control groups (Student’s 
t-test, P<0.05). Bars: A and B, D and E: 50 μm.
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8animals compared with controls (Fig. 4 A-C). Because the 
number of myofibroblasts is expected to increase during 
tubulointerstitial fibrosis in diabetic nephropathy, we 
analyzed their presence through the expression of alpha-
smooth muscle actin (α-SMA), observing a significant 
increase in the number of myofibroblasts located in the 
tubulointerstitium of T1DM animals (Fig. 4 D-F) compared 
with age-matched control mice.
As markers of proximal tubule injury, we first exam-
ined the urinary activity of ALP and GGT. Both enzymes 
were significantly increased in the urine of diabetic animals 
(Fig. 5 A and B) compared with the control group. Further-
more, we explored urinary albumin levels in T1DM and 
control animals, observing a significant increase after the 
development of diabetic nephropathy (Fig. 5 C). The ob-
served urinary protein loss was probably related to the alter-
ation of tubular endocytic transporters megalin and cubilin 
because of the significant increase in urinary excretion of 
VDBP in T1DM animals (Fig. 5 D), and also because of the 
decrease in intracellular albumin trafficking, evidenced by 
the reduction in labeled albumin in proximal tubule cells 
(Fig. 5 E-J).
Megalin and cubilin in diabetic nephropathy induced by 
type 1 diabetes mellitus
After the observation of tubular injury induced by diabetic 
nephropathy and the alteration of functional reabsorption 
as evidenced by the increased urinary levels of albumin and 
VDBP, we analyzed the specific proximal tubule protein 
transporters megalin and cubilin.
We observed a significant decrease in megalin mRNA 
expression (RT-qPCR) (Fig. 6 G) and its surface abundance 
(IFI) (Fig. 6 A-C) in T1DM animals, as well as a not signif-
icant decrease in cubilin for the same parameters (Fig. 6 H 
and D-F). We also found a significant decrease in the total 
amount of both proteins as determined by immunoblot (Fig. 
6 I and J).
Mechanisms involved in alteration of endocytic albumin 
transporters
We studied two mechanisms that could be associated with 
the alteration of albumin transporters: malfunctioning of 
intracellular trafficking of megalin and cubilin and shedding 
of these transporters from the tubular brush border.
For the analysis of intracellular trafficking of both 
transporters, we analyzed the co-expression of megalin 
and cubilin with a marker of late endosomes (LBPA). We 
observed a markedly reduced expression of megalin and 
cubilin in the proximal tubule cells of T1DM animals (Fig. 
7 B, D, F, and H). LBPA-labeled vesicles were uniformly 
distributed on the surface of the proximal tubule epithelium 
of control animals (Fig. 7 A and C), but in T1DM animals 
the vesicles were increased and accumulated in regions of 
the tubule, and the superficial pattern observed in control 
animals was lost (Fig. 7 E and G). Furthermore, we found 
that T1DM animals showed an increased number of tubules 
with this pattern of LBPA-labeled vesicles (Score = Control: 
0.75 vs. T1DM: 2.75).
Metalloprotease expression in the proximal tubule cells 
was increased in T1DM animals when compared to the con-
trols (Fig. 8 A-C). In addition, we observed a not significant 
increase in urine albumin transporter levels (cubilin) in 
T1DM animals compared to control mice (Fig. 8 D).
FIGURE 7. Evaluation of subcellular trafficking of albumin transporters (megalin and cubilin) in T1DM animals after 
10 weeks of diabetes. Images from the upper panels show the presence of LBPA protein (arrowheads) and their 
co-localization with megalin and cubilin in control (A-D) and T1DM animals (E-H) (N = 4). Bars: 25 μm.
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9Discussion
Proteinuria has classically been described as the hallmark 
of diabetic nephropathy (Moresco, RN et al., 2013). The 
characteristic pathological changes observed in diabetic 
nephropathy, such as the injury of glomerular endothelial 
cells, glomerular basement membrane, and podocytes, have 
an important role at advanced stages of diabetic nephropathy, 
but do not include all pathogenic mechanisms that cause 
proteinuria in diabetes mellitus (Jefferson, J et al., 2008; 
Vallon, V, 2011; Vallon, V & Komers, R, 2011). In a previous 
work (Ezquer, F et al., 2015), we observed that after 10 weeks 
of diabetes the animals showed a significant increase in 
albuminuria, but plasmatic creatinine levels, widely used to 
show signs of glomerular alteration and renal malfunction 
(Semedo, P et al., 2009), were not significantly different until 
after 16 weeks of disease. At the earliest stages of diabetes 
(10 weeks), the kidneys showed some podocyte alteration 
but the function of the glomeruli apparently remained 
unaltered with high levels of albuminuria. It is possible that 
other mechanisms usually overlooked, like the effect of 
tubulointerstitial injury over the proximal tubule albumin 
transport, could have a central role in trying to understand 
the mechanisms underlying proteinuria. 
Indeed, proteinuria is not only a marker of the 
progression of renal disease, but also has an essential role 
in the pathogenesis of diabetic nephropathy (Abbate, M et 
al., 2006; Jefferson, J et al., 2008; Zoja, C et al., 2014). It has 
been demonstrated that the consequent protein reuptake 
throughout the nephron has stimulatory effects on the 
expression of pro-inflammatory and pro-fibrotic mediators 
in kidney tubular cells (Nath, KA, 1992; Tang, S et al., 2003), 
especially by the ability of albumin to act as a carrier of pro-
inflammatory substances (Kamijo, A et al., 2002; Abbate, M 
et al., 2006; Urahama, Y et al., 2008). Albumin reabsorption 
has been shown to be reduced in early diabetic nephropathy 
(Tojo, A et al., 2001), but the underlying mechanisms 
are complex and not fully understood. In this work, we 
observed a significant increase in albuminuria in diabetic 
animals correlated with the development of tubulointerstitial 
fibrosis and the observation of tubular cell damage at an 
ultrastructural level. Furthermore, this pathological process 
was accompanied by tubular injury as evidenced by an 
increase in urinary enzyme excretion.
Recently, it has also been suggested that the function 
and/or expression of megalin and cubilin may be altered 
in the early stages of diabetic nephropathy (Saito, A et al., 
2010). We observed that tubulointerstitial injury in T1DM 
goes hand in hand with the alteration of megalin and cubi-
lin, which is involved in the physiologic uptake of proteins 
from the tubule. The ability of both transporters to reabsorb 
proteins (as demonstrated by VDBP transport and affecta-
tion in intracellular albumin trafficking) was reduced in 
diabetic mice. Furthermore, protein and mRNA expression 
of megalin were clearly reduced in T1DM animals (as was 
the total amount of cubilin shown by immunoblot). In ear-
ly stages of diabetic nephropathy in experimental animals, a 
decrease in megalin expression of proximal tubular cells has 
also been observed (Tojo, A et al., 2001; Yamashita, T et al., 
2012). Likewise, protein reuptake has been related to high 
glucose levels in tubular cells (Ishibashi, F, 2004).
Autophagy is a catabolic process that maintains cellu-
lar homeostasis under intra- or extra-cellular stress condi-
tions, helping cells to avoid apoptosis. Proximal tubule cell 
apoptosis was shown to contribute to tubular atrophy and 
glomerular-tubule disconnection during proteinuria (Be-
nigni, A et al., 2001). Recent attention has been given to the 
participation of autophagy in the pathogenesis of diabetic 
nephropathy, essentially because of increasing evidence re-
lated to the impaired autophagic activity in diabetic kidney 
cells (Yamahara, K et al., 2013; Ding, Y & Choi, ME, 2015). 
Furthermore, tubular epithelial cells show low levels of auto-
phagy under physiological conditions (Liu, S et al., 2012). In 
our study, we observed an increase in the cellular degradative 
process in cells from the proximal tubules of T1DM animals, 
as shown by an increase in the relative number of tubules 
FIGURE 8. Evaluation of shedding of albumin transporters and their re-
lationship with metalloprotease (MMP-2) expression in T1DM mice 10 
weeks after diabetes induction. (A-C) Immunofluorescence analysis of 
MMP-2 levels (arrowheads) in kidney cortical tubules of control and 
T1DM animals. (D) Urinary excretion of protein transporters (cubilin) mea-
sured by Western blot. Values are mean ± SEM, N = 6. Horizontal brack-
ets indicate significant differences between control and T1DM animals 
(Student’s t-test, P<0.05). Bars: A and B: 50 μm.
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from diabetic animals with numerous LBPA-labeled vesicles 
and many of these vesicles showed ultrastructural character-
istics of autophagosomes. The alteration of the normal endo-
cytic recycling pathway may be associated with the decrease 
in megalin and cubilin on the epithelial surface also observed 
in this work.
Another proposed mechanism linked to the alteration 
of proximal tubule albumin transporters is the shedding 
of receptors from the epithelial surface (Christensen, EI et 
al., 2012). The shedding of albumin transporters decreases 
the amount of available protein receptors and has also been 
associated with a direct decrease in protein synthesis as a 
consequence of an increase in the number of soluble frag-
ments of this receptor trafficked to the nucleus, which could 
down-regulate gene expression (Biemesderfer, D, 2006). This 
could be related to the results we obtained for mRNA trans-
porter expression. The increase in the urinary excretion of 
megalin, cubilin, and megalin fragments has been proposed 
as a marker of the progression of diabetic nephropathy 
(Thrailkill, KM et al., 2009; Ogasawara, S et al., 2012). As far 
as we know, while the presence of megalin and its fragments 
in urine has been reported previously, the presence of cubilin 
has not. In our study, we observed a significant increase in 
the presence of tubular metalloproteases in T1DM animals 
that could be associated with the shedding of albumin trans-
porters. We found cubilin in the urine, but we did not discov-
er significant differences when its levels were compared with 
controls. Our results, and the results previously described re-
porting the increase in urinary megalin in diabetic patients 
(Thrailkill, KM et al., 2009; Ogasawara, S et al., 2012), suggest 
that the shedding of megalin probably has a more important 
role as a pathogenic mechanism than that of cubilin. Like-
wise, our observations of the accumulation of LBPA-labeled 
vesicles in diabetic nephropathy tubules could contribute 
to the down-regulatory effect, and both mechanisms could 
contribute to the decrease in megalin and cubilin expression 
and to the renal dysfunction observed in our study.
The reduction in megalin expression and albumin 
endocytosis in T1DM rats with diabetic nephropathy was 
described almost 15 years ago (Tojo, A et al., 2001), but 
the question proposed by researchers about other possi-
ble mechanisms that could cause damage of the intracel-
lular trafficking and degradation systems has not yet been 
completely clarified. In this work, we extensively explored 
albumin transport in the proximal tubule cells of early di-
abetic nephropathy in type 1 diabetic animals. The patho-
physiological mechanisms involved in the development of 
diabetic nephropathy in T1DM animals is clearly related to 
a reduction in tubular protein reabsorption associated with 
tubulointerstitial injury and fibrosis, with an increase of cel-
lular metalloproteases (Fig. 9). Both of these mechanisms 
induce a decrease in the expression of megalin and cubilin 
in T1DM animals at early stages of diabetic nephropathy 
(Fig. 9), which could be related to the significant increase 
in albumin and VDBP urinary excretion. We also observed 
another recently described pathophysiological mechanism 
that could be associated with tubular injury, i.e., the increase 
in the amount of vesicles from the phagocytic system in the 
proximal tubule. The alteration of the autophagic machinery 
in diabetic tubular cells could partially explain the malfunc-
tion of megalin and cubilin albumin transporters that could 
be linked to the development and progression of proteinuria 
(Fig. 9). The alteration of megalin and cubilin at early stages 
of diabetic nephropathy could contribute to the other patho-
genic mechanisms acting during the evolution of diabetic 
nephropathy to induce progressive kidney damage (Fig. 9).
We hope that our work will begin to enlighten the tubular 
intracellular mechanisms affected by diabetic nephropathy, 
FIGURE 9. Proposed role of megalin and cubilin alteration during early 
diabetic nephropathy induced by type 1 diabetes mellitus. The multifac-
torial pathogenic mechanisms that induce glomerular and tubular injury 
produce an increase in albumin tubular levels that eventually affects the 
functionality and expression of megalin and cubilin. Injury of these trans-
porters along with the other damaging effects of diabetes on the kidneys 
leads to progression of diabetic nephropathy. 
MAXIMILIANO GIRAUD-BILLOUD et al.
11
with special focus on proteinuria, and that this growing field 
of study will help researchers find new therapeutics directed 
at preventing the development of diabetic kidney disease.
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